**Core Concept:** Squint (also known as strabismus) is a condition in which the eyes appear to be misaligned, either horizontally, vertically, or diagonally. In children, squint can be congenital (present at birth) or acquired (developing later in life). Treatment for squint depends on the cause and severity of the misalignment. One common treatment option is the use of cycloplegic agents to relax the ciliary muscles and achieve eye dilation.

**Why the Correct Answer is Right:** The correct answer is Cyclopentolate (Drug C) because it is a cycloplegic agent, a type of topical eye drop used to relax the ciliary muscles and reduce the accommodation response in the eye. This is essential in the treatment of squint in children, as cycloplegia helps align the eyes by reducing the convergence force between the two eyes.

**Why Each Wrong Option is Incorrect:**

A. Phenylephrine (Drug A) is a sympathomimetic drug that increases intraocular pressure (IOP) in the eye. It would not be suitable for dilating the eye in a child with squint because it raises IOP, which may worsen the squint condition.

B. Tropicamide (Drug B) is another cycloplegic agent, but it is generally preferred over cyclopentolate because of shorter duration of action and better safety profile. Cyclopentolate tends to cause prolonged pupillary dilation, which may not be ideal for a child with squint, especially in a clinical setting where quick assessment is crucial.

D. Proparacaine (Drug D) is a topical anesthetic used to numb the eye surface and is not a cycloplegic agent. It is used for pain relief during eye examination or surgery and does not help in dilating the eye for squint treatment.

**Clinical Pearl:**

In children with squint, cyclopentolate is often used in combination with tropicamide to achieve a longer duration of action and better safety profile. However, in this scenario, cyclopentolate is the correct answer due to its longer duration of action, which is essential for thorough assessment and treatment of squint in a child. The primary concern is to dilate the pupil sufficiently to align the eyes and assess the alignment accurately, which cyclopentolate achieves effectively.